Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Severe COVID-19 Requiring Mechanical Ventilation
NCT04616001Phase 4Unknown
- Sponsor
- Sharp HealthCare
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Human normal immunoglobulin G in coronavirus disease 2019 (COVID-19), sponsored by Sharp HealthCare. Status: unknown.
02
Drugs
Human normal immunoglobulin G
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04616001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04616001.